Staphylococcus aureus COL : An Atypical Model Strain of MRSA That Exhibits Slow Growth and Antibiotic Tolerance due to a Mutation in PRPP Synthetase
Molecular Microbiology · 2025-09 · 124 (3) · 189-203
DOI: 10.1111/mmi.70000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Microbiology, online erschienen am 09.06.2025. Verfasst von Claire E Stevens und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews, UK. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Ribose-Phosphate Pyrophosphokinase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR Doctoral Foreign Study Award, CIHR, Academy of Medical Sciences.
Abstract (Originalsprache)
Methicillin‐resistant Staphylococcus aureus (MRSA) has been a pathogen of global concern since its emergence in the 1960s. As one of the first MRSA strains isolated, COL has become a common model strain of S. aureus . Here we report that COL is, in fact, an atypical strain of MRSA that exhibits slow growth and multidrug tolerance. Genomic analysis identified three mutated genes in COL ( rpoB, gltX and prs ) with links to tolerance. Allele swapping experiments between COL and the closely‐related, nontolerant Newman strain uncovered a complex interplay between these genes. However, Prs (phosphoribosyl pyrophosphate [PRPP] synthetase) accounted for most of the growth and tolerance phenotype of COL. Biochemical and transcriptomic analysis revealed that COL does not exhibit slow growth as a result of partial stringent response activation, as previously proposed. Instead, the COL Prs mutation greatly reduces the PRPP synthetase activity of the enzyme and leads to downregulation of pyrimidine, histidine, and tryptophan synthesis, three pathways that rely on PRPP. Overall, our findings indicate that COL is an atypical, antibiotic‐tolerant strain of MRSA whose isolation predates the previous first report of tolerance among clinical isolates. Characterization of clinical Prs mutations and their relationship with tolerance requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews, UK.
- School of Medicine, University of St Andrews, St Andrews, UK.
- Biomedical Sciences Research Complex, School of Chemistry, University of St Andrews, St Andrews, UK.
- Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
ORCID-Profile: Paul R Johnston, Joanne K Hobbs
Förderung
- CIHR Doctoral Foreign Study Award
- CIHR
- Academy of Medical Sciences
- Canadian Institutes of Health Research
Zitieren
APA
Stevens, C. E., Deventer, A. T., Johnston, P. R., Lowe, P. T., Boraston, A. B., & Hobbs, J. K. (2025). Staphylococcus aureus COL : An Atypical Model Strain of MRSA That Exhibits Slow Growth and Antibiotic Tolerance due to a Mutation in PRPP Synthetase. Molecular Microbiology, 124(3), 189-203. https://doi.org/10.1111/mmi.70000
Vancouver
Stevens CE, Deventer AT, Johnston PR, Lowe PT, Boraston AB, Hobbs JK. Staphylococcus aureus COL : An Atypical Model Strain of MRSA That Exhibits Slow Growth and Antibiotic Tolerance due to a Mutation in PRPP Synthetase. Molecular Microbiology. 2025;124(3):189-203. doi:10.1111/mmi.70000
BibTeX
@article{Stevens2025,
author = {Stevens, Claire E and Deventer, Ashley T and Johnston, Paul R and Lowe, Phillip T and Boraston, Alisdair B and Hobbs, Joanne K},
title = {Staphylococcus aureus COL : An Atypical Model Strain of MRSA That Exhibits Slow Growth and Antibiotic Tolerance due to a Mutation in PRPP Synthetase},
journal = {Molecular Microbiology},
year = {2025},
volume = {124},
number = {3},
pages = {189--203},
doi = {10.1111/mmi.70000}
}
EUVIMED